Dr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects.

RDY misses on earnings but beats on revenues in the fiscal second quarter. The bottom line suffers due to a one-time ...

Dr. Reddy’s Laboratories’ (DRL ... Acquisition of NRT business from Haleon, consolidation of Sanofi’s vaccine portfolio ...

Indian generic drugmaker Dr Reddy's Laboratories recorded a 9.5 percent decline in its consolidated net profit after tax to ...

Aadhar Housing Finance, Power Grid Corporation of India, and Jindal Steel & Power will be releasing their Q2FY25 results ...

Dr Reddy’s Laboratories posted a mixed performance in Q2FY25, reporting record revenue of Rs 8,038.2 crore, marking a strong ...

HYDERABAD/BENGALURU (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories' second-quarter profit was hit by one-time charges related to its joint venture with Nestle India and Nicotinell ...

Dr. Reddy’s is one of the largest generic drug manufacturers in the world. Global generics make up over 85% of the firm's sales, and along with other generics manufacturers, it continues to suffer low ...

Dr. Reddy's Laboratories Limited ( NYSE: RDY) Q2 2025 Earnings Conference Call November 5, 2024 9:00 AM ET Richa Periwal - Head of Investor Relations MV Narasimham - Chief Financial Officer Erez ...

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

Consumer healthcare company Haleon has chosen ad tech firm Vistar Media as its preferred partner for programmatic out-of-home across its key markets, the companies announced today. Via the ...

Consumer healthcare firm Haleon has chosen Vistar Media as its preferred partner for programmatic OOH across all key markets. Through this partnership, Vistar will collaborate with Publicis ...